Literature DB >> 33430105

The Functional Crosstalk between Myeloid-Derived Suppressor Cells and Regulatory T Cells within the Immunosuppressive Tumor Microenvironment.

Maximilian Haist1, Henner Stege1, Stephan Grabbe1, Matthias Bros1.   

Abstract

Immune checkpoint inhibitors (ICI) have led to profound and durable tumor regression in some patients with metastatic cancer diseases. However, many patients still do not derive benefit from immunotherapy. Here, the accumulation of immunosuppressive cell populations within the tumor microenvironment (TME), such as myeloid-derived suppressor cells (MDSC), tumor-associated macrophages (TAM), and regulatory T cells (Treg), contributes to the development of immune resistance. MDSC and Treg expand systematically in tumor patients and inhibit T cell activation and T effector cell function. Numerous studies have shown that the immunosuppressive mechanisms exerted by those inhibitory cell populations comprise soluble immunomodulatory mediators and receptor interactions. The latter are also required for the crosstalk of MDSC and Treg, raising questions about the relevance of cell-cell contacts for the establishment of their inhibitory properties. This review aims to outline the current knowledge on the crosstalk between these two cell populations, issuing particularly the potential role of cell adhesion molecules. In this regard, we further discuss the relevance of β2 integrins, which are essential for the differentiation and function of leukocytes as well as for MDSC-Treg interaction. Lastly, we aim to describe the impact of such bidirectional crosstalk for basic and applied cancer research and discuss how the targeting of these pathways might pave the way for future approaches in immunotherapy.

Entities:  

Keywords:  CD11; CD18; Keywords: myeloid-derived suppressor cells; cell–cell contact; crosstalk; immunotherapy; regulatory T cells; tumor immune evasion; tumor microenvironment; β2 integrins

Year:  2021        PMID: 33430105     DOI: 10.3390/cancers13020210

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  21 in total

Review 1.  Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment.

Authors:  Alain E Andrea; Andrada Chiron; Sarah Mallah; Stéphanie Bessoles; Guillaume Sarrabayrouse; Salima Hacein-Bey-Abina
Journal:  Front Immunol       Date:  2022-02-08       Impact factor: 7.561

Review 2.  Payload Delivery: Engineering Immune Cells to Disrupt the Tumour Microenvironment.

Authors:  Daniel Fowler; Callum Nattress; Alba Southern Navarrete; Marta Barisa; Jonathan Fisher
Journal:  Cancers (Basel)       Date:  2021-11-29       Impact factor: 6.639

3.  In vitro preliminary study on different anti-PD-1 antibody concentrations on T cells activation.

Authors:  Irena Wieleba; Kamila Wojas-Krawczyk; Izabela Chmielewska; Magdalena Wójcik-Superczyńska; Paweł Krawczyk; Janusz Milanowski
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

Review 4.  Nanodrugs Targeting T Cells in Tumor Therapy.

Authors:  Maximilian Haist; Volker Mailänder; Matthias Bros
Journal:  Front Immunol       Date:  2022-05-25       Impact factor: 8.786

Review 5.  MDSCs and T cells in solid tumors and non-Hodgkin lymphomas: an immunosuppressive speech.

Authors:  Chiara Cioccarelli; Barbara Molon
Journal:  Clin Exp Immunol       Date:  2022-06-11       Impact factor: 5.732

6.  Editorial on Special Issue "Immunotherapy, Tumor Microenvironment and Survival Signaling".

Authors:  Vita Golubovskaya
Journal:  Cancers (Basel)       Date:  2021-12-24       Impact factor: 6.639

Review 7.  Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer.

Authors:  Kai Li; Houhui Shi; Benxia Zhang; Xuejin Ou; Qizhi Ma; Yue Chen; Pei Shu; Dan Li; Yongsheng Wang
Journal:  Signal Transduct Target Ther       Date:  2021-10-07

Review 8.  Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End.

Authors:  Angeliki Datsi; Rüdiger V Sorg
Journal:  Front Immunol       Date:  2021-11-02       Impact factor: 7.561

Review 9.  The Role of p53 Dysfunction in Colorectal Cancer and Its Implication for Therapy.

Authors:  Maurice Michel; Leonard Kaps; Annett Maderer; Peter R Galle; Markus Moehler
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

10.  Inducible T-Cell Costimulator Ligand Plays a Dual Role in Melanoma Metastasis upon Binding to Osteopontin or Inducible T-Cell Costimulator.

Authors:  Davide Raineri; Giuseppe Cappellano; Beatrice Vilardo; Federica Maione; Nausicaa Clemente; Elena Canciani; Elena Boggio; Casimiro Luca Gigliotti; Chiara Monge; Chiara Dianzani; Renzo Boldorini; Umberto Dianzani; Annalisa Chiocchetti
Journal:  Biomedicines       Date:  2021-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.